Home Cart 0 Sign in  
X

[ CAS No. 65515-32-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 65515-32-4
Chemical Structure| 65515-32-4
Chemical Structure| 65515-32-4
Structure of 65515-32-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 65515-32-4 ]

Related Doc. of [ 65515-32-4 ]

Alternatived Products of [ 65515-32-4 ]

Product Details of [ 65515-32-4 ]

CAS No. :65515-32-4 MDL No. :MFCD15142741
Formula : C8H8ClNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :KUJLWEWWBOZDRR-UHFFFAOYSA-N
M.W : 201.61 Pubchem ID :10560015
Synonyms :

Calculated chemistry of [ 65515-32-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.02
TPSA : 48.42 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.3
Log Po/w (XLOGP3) : 1.97
Log Po/w (WLOGP) : 1.53
Log Po/w (MLOGP) : 1.07
Log Po/w (SILICOS-IT) : 1.85
Consensus Log Po/w : 1.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.47
Solubility : 0.676 mg/ml ; 0.00335 mol/l
Class : Soluble
Log S (Ali) : -2.61
Solubility : 0.492 mg/ml ; 0.00244 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.85
Solubility : 0.285 mg/ml ; 0.00141 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.97

Safety of [ 65515-32-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 65515-32-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 65515-32-4 ]
  • Downstream synthetic route of [ 65515-32-4 ]

[ 65515-32-4 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 65515-32-4 ]
  • [ 65515-33-5 ]
Reference: [1] Patent: US4089960, 1978, A,
  • 2
  • [ 124-41-4 ]
  • [ 65515-28-8 ]
  • [ 65515-32-4 ]
YieldReaction ConditionsOperation in experiment
94% at -5 - 20℃; for 16 h; Step 2: methyl 6-chloro-2-methoxynicotinate; To a solution of 2,6-dichloro-nicotinic acid methyl ester (105 g, 0.5 mol) in dichloromethane (523 mL) at -5°C was added sodium methoxide (34.25 g, 0.63 mol) in one portion. The reaction was allowed to warm to room temperature over 4 hours. Additional sodium methoxide (5.48 g, 0.10 mol) was added and the mixture was stirred for 12 h. To the reaction was added saturated aqueous sodium bicarbonate (300 mL), water (400 mL) and dichloromethane (300 mL). The layers were separated and the aqueous layer was washed with dichloromethane (200 mL). The combined organic layers were washed with water (500 mL), dried with magnesium sulfate and filtered through celite. The filtrate was concentrated to an oil that solidified to yield the title compound (95 g, 94percent). 1H NMR (500 MHz, DMSO-d6) δ ppm 3.81 (3 H, s), 3.93 (3 H, s), 7.21 (1 H, d, J=7.8 Hz), 8.18 (1 H, d, J=7.8 Hz).
94% at -5 - 20℃; for 16 h; To a solution of methyl ester 10 (105 g, 0.5 mol) in dichloromethane (523 mL) at -5 °C was added sodium methoxide (34.25 g, 0.63 mol) in one portion. The reaction was allowed to warm to room temperature over 4 hours. Additional sodium methoxide (5.48 g, 0.10 mol) was added. After 12 h, saturated aqueous sodium bicarbonate (300 mL), water (400 mL) and dichloromethane (300 mL) were added. The layers were separated and the aqueous layer was extracted with dichloromethane (200 mL). The combined organic layers were washed with water (500 mL), dried over MgSO4 and filtered through Celite. The filtrate was concentrated to an oil that solidified to yield 11 (95 g, 94percent). 1H NMR (500 MHz, DMSO-d6) δ 8.18 (1H, d, J=7.8 Hz), 7.21 (1H, d, J=7.8 Hz), 3.93 (3H, s), 3.81 (3H, s).
70% at 0℃; for 3 h; To a solution of 2,6-dichloro-nicotinic acid methyl ester (20.0 g, 0.1 mol) in dichloromethane (80 ml) at 0 0C was added NaOMe (8.1 g, 0.15 mol) slowly and stirred at 0 0C for 3h. The reaction mixture was diluted with water, the organic layer was dried with sodium sulfate and evaporated to give an oily product which slowly solidified into a white solid (14.Og, w o ).
Reference: [1] Patent: WO2010/116282, 2010, A1, . Location in patent: Page/Page column 53
[2] Tetrahedron Letters, 2011, vol. 52, # 52, p. 7025 - 7029
[3] Patent: WO2006/112828, 2006, A1, . Location in patent: Page/Page column 58
[4] Patent: US2005/119251, 2005, A1, . Location in patent: Page/Page column 20; 22
[5] Patent: WO2006/14168, 2006, A1, . Location in patent: Page/Page column 47
[6] Patent: WO2016/54807, 2016, A1, . Location in patent: Page/Page column 76
  • 3
  • [ 58584-86-4 ]
  • [ 65515-32-4 ]
Reference: [1] Patent: EP2085383, 2009, A1, . Location in patent: Page/Page column 22
  • 4
  • [ 65515-28-8 ]
  • [ 65515-32-4 ]
Reference: [1] Patent: US4089960, 1978, A,
  • 5
  • [ 38496-18-3 ]
  • [ 65515-32-4 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
[2] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
[3] Tetrahedron Letters, 2011, vol. 52, # 52, p. 7025 - 7029
[4] Patent: WO2016/54807, 2016, A1,
[5] ChemMedChem, 2016, vol. 11, # 8, p. 827 - 833
  • 6
  • [ 124-41-4 ]
  • [ 65515-28-8 ]
  • [ 65515-32-4 ]
  • [ 65515-26-6 ]
  • [ 95652-77-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
[2] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
  • 7
  • [ 124-41-4 ]
  • [ 65515-28-8 ]
  • [ 65515-32-4 ]
  • [ 95652-77-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
  • 8
  • [ 67-56-1 ]
  • [ 65515-33-5 ]
  • [ 65515-32-4 ]
Reference: [1] ChemMedChem, 2016, vol. 11, # 8, p. 827 - 833
  • 9
  • [ 67-56-1 ]
  • [ 38496-18-3 ]
  • [ 65515-32-4 ]
  • [ 65515-26-6 ]
Reference: [1] Synlett, 2011, # 2, p. 203 - 206
  • 10
  • [ 124-41-4 ]
  • [ 65515-28-8 ]
  • [ 65515-32-4 ]
  • [ 65515-26-6 ]
  • [ 95652-77-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
[2] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
  • 11
  • [ 67-56-1 ]
  • [ 38496-18-3 ]
  • [ 65515-32-4 ]
  • [ 65515-26-6 ]
Reference: [1] Synlett, 2011, # 2, p. 203 - 206
  • 12
  • [ 65515-32-4 ]
  • [ 121643-46-7 ]
Reference: [1] Patent: WO2016/54807, 2016, A1,
  • 13
  • [ 124-41-4 ]
  • [ 65515-28-8 ]
  • [ 65515-32-4 ]
  • [ 65515-26-6 ]
  • [ 95652-77-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
[2] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
  • 14
  • [ 124-41-4 ]
  • [ 65515-28-8 ]
  • [ 65515-32-4 ]
  • [ 95652-77-0 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2000, vol. 48, # 12, p. 1847 - 1853
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 65515-32-4 ]

Chlorides

Chemical Structure| 38076-76-5

[ 38076-76-5 ]

6-Chloro-2-hydroxynicotinic acid

Similarity: 0.91

Chemical Structure| 95652-81-6

[ 95652-81-6 ]

6-Chloro-2-methoxynicotinaldehyde

Similarity: 0.84

Chemical Structure| 15855-06-8

[ 15855-06-8 ]

2-Chloro-6-methoxypyridine-4-carboxylic Acid

Similarity: 0.84

Chemical Structure| 1256826-55-7

[ 1256826-55-7 ]

Methyl 4-chloro-2-methoxynicotinate

Similarity: 0.80

Chemical Structure| 73781-91-6

[ 73781-91-6 ]

Methyl 6-chloronicotinate

Similarity: 0.80

Ethers

Chemical Structure| 67367-26-4

[ 67367-26-4 ]

Methyl 2-methoxynicotinate

Similarity: 0.87

Chemical Structure| 95652-81-6

[ 95652-81-6 ]

6-Chloro-2-methoxynicotinaldehyde

Similarity: 0.84

Chemical Structure| 15855-06-8

[ 15855-06-8 ]

2-Chloro-6-methoxypyridine-4-carboxylic Acid

Similarity: 0.84

Chemical Structure| 16498-81-0

[ 16498-81-0 ]

2-Methoxynicotinic acid

Similarity: 0.83

Chemical Structure| 1256826-55-7

[ 1256826-55-7 ]

Methyl 4-chloro-2-methoxynicotinate

Similarity: 0.80

Esters

Chemical Structure| 67367-26-4

[ 67367-26-4 ]

Methyl 2-methoxynicotinate

Similarity: 0.87

Chemical Structure| 67383-31-7

[ 67383-31-7 ]

Methyl 2-hydroxynicotinate

Similarity: 0.81

Chemical Structure| 1256826-55-7

[ 1256826-55-7 ]

Methyl 4-chloro-2-methoxynicotinate

Similarity: 0.80

Chemical Structure| 73781-91-6

[ 73781-91-6 ]

Methyl 6-chloronicotinate

Similarity: 0.80

Chemical Structure| 65515-26-6

[ 65515-26-6 ]

Methyl 2,6-dimethoxynicotinate

Similarity: 0.78

Related Parent Nucleus of
[ 65515-32-4 ]

Pyridines

Chemical Structure| 38076-76-5

[ 38076-76-5 ]

6-Chloro-2-hydroxynicotinic acid

Similarity: 0.91

Chemical Structure| 67367-26-4

[ 67367-26-4 ]

Methyl 2-methoxynicotinate

Similarity: 0.87

Chemical Structure| 95652-81-6

[ 95652-81-6 ]

6-Chloro-2-methoxynicotinaldehyde

Similarity: 0.84

Chemical Structure| 15855-06-8

[ 15855-06-8 ]

2-Chloro-6-methoxypyridine-4-carboxylic Acid

Similarity: 0.84

Chemical Structure| 16498-81-0

[ 16498-81-0 ]

2-Methoxynicotinic acid

Similarity: 0.83